Literature DB >> 10564754

CTL epitopes identified with a defective recombinant adenovirus expressing measles virus nucleoprotein and evaluation of their protective capacity in mice.

E B Schadeck1, C D Partidos, A R Fooks, O E Obeid, G W Wilkinson, J R Stephenson, M W Steward.   

Abstract

Cytotoxic T-lymphocyte (CTL) responses to measles virus (MV) play an important role in recovery from infection, with one of the major target proteins for CTL activity being the nucleoprotein (Np). In this report, a replication-deficient adenovirus-5 recombinant, expressing for MV Np (Rad68) was tested for in vivo priming of MV Np-specific CTL responses in BALB/c and CBA mice. In both strains of mice strong Np-specific CTL responses were induced and these responses were shown to be MHC class I restricted. Using overlapping 15mer peptides spanning residues 1-505 of MV Np a single epitope comprising residues 281-295 was identified in BALB/c mice whereas, in CBA mice two epitopes comprising residues 51-65 and 81-95, were identified. These epitopes were found to contain class I motifs for H-2L(d) and H-2K(k) MHC molecules, respectively. Immunization of BALB/c and CBA mice with the respective CTL epitopes resulted in the in vivo induction of peptide-and MV Np-specific CTL responses. In addition, the identified H-2K(k) restricted CTL epitopes conferred some protection against encephalitis induced following intracerebral challenge with a lethal dose of canine distemper virus (the Np of which shares 70% sequence homology with MV Np). These findings highlight the potential of using well-defined CTL epitopes to control virus infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564754     DOI: 10.1016/s0168-1702(99)00103-3

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  9 in total

1.  Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.

Authors:  Mark A Brockman; David M Knipe
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

3.  Characterization of measles virus strains causing SSPE: a study of 11 cases.

Authors:  L Jin; S Beard; R Hunjan; D W G Brown; E Miller
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

4.  An immune competent mouse model for the characterization of recombinant measles vaccines.

Authors:  René R Marty; Marlyse C Knuchel; Teldja Neige Azzouz Morin; Hussein Y Naim
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

5.  Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes.

Authors:  Marcela F Pasetti; Rosangela Salerno-Gonçalves; Marcelo B Sztein
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

6.  Construction and immunological evaluation of recombinant adenovirus vaccines co-expressing GP3 and GP5 of EU-type porcine reproductive and respiratory syndrome virus in pigs.

Authors:  Changzhan Xie; Zhuo Ha; Wenchao Sun; Fulong Nan; Ping Zhang; Jicheng Han; Guanyu Zhao; He Zhang; Xinyu Zhuang; Huijun Lu; Ningyi Jin
Journal:  J Vet Med Sci       Date:  2019-11-07       Impact factor: 1.267

7.  Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice.

Authors:  Huali Jin; Chong Xiao; Ze Chen; Youmin Kang; Yijie Ma; Kaichun Zhu; Qifa Xie; Yixian Tu; Yang Yu; Bin Wang
Journal:  Biochem Biophys Res Commun       Date:  2005-03-25       Impact factor: 3.575

Review 8.  Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

Authors:  Anne S De Groot; Leo Einck; Leonard Moise; Michael Chambers; John Ballantyne; Robert W Malone; Matthew Ardito; William Martin
Journal:  Hum Vaccin Immunother       Date:  2013-07-22       Impact factor: 3.452

9.  Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine.

Authors:  Min-Sheng Zhu; Ying Pan; Hua-Qun Chen; Yue Shen; Xiao-Chun Wang; Yong-Jun Sun; Kai-Hua Tao
Journal:  Immunol Lett       Date:  2004-04-15       Impact factor: 3.685

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.